Buying Bayer Rights, Celera Axes Axys Collaboration | GenomeWeb

NEW YORK, Oct. 8 - Celera Genomics has bought from Bayer all rights to preclinical research held under an existing collaboration between the two companies. In the process, Celera has untied a research partnership in place since before the Applera unit bought Axys Pharmaceuticals last year.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.